China SXT Pharmaceuticals Inc (SXTC) — Free Cash Flow Generation Index

Latest as of December 2022: 0.89x

China SXT Pharmaceuticals Inc (SXTC) has a Free Cash Flow Generation Index of 0.89x as of December 2022. Free cash flow of $208.90K represents 1% of operating cash flow ($234.18K). Read debt load of China SXT Pharmaceuticals Inc for a breakdown of total debt and financial obligations.

FCF Generation Index

0.89x
Free Cash Flow / Operating CF

Free Cash Flow

$208.90K
USD

Operating Cash Flow

$234.18K
USD

Capital Expenditures

$25.28K
USD

China SXT Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2022)

Historical FCF Generation Index trend for China SXT Pharmaceuticals Inc across 6 annual periods. Explore how much does China SXT Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for China SXT Pharmaceuticals Inc (2016–2022)

Year-by-year Free Cash Flow Generation Index for China SXT Pharmaceuticals Inc. For the full company profile including market capitalisation, see SXTC company net worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.77x $205.80K $268.29K $62.49K ▲ +35.8%
2020 0.56x $527.59K $934.25K $406.66K ▲ +136.4%
2019 -1.55x $-370.89K $239.19K $610.09K ▼ -442.5%
2018 0.45x $869.44K $1.92 Million $1.05 Million ▲ +24.3%
2017 0.36x $106.73K $293.04K $186.31K ▼ -22.3%
2016 0.47x $85.48K $182.47K $96.99K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).